ArticleDiscover oncology2025
Pan-cancer analysis of the impact of fatty acids: a two-sample and multivariable Mendelian randomization study.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Historical rise of cancer and dietary linoleic acid: Mechanisms and therapeutic strategies.World journal of clinical oncology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThis study used Mendelian randomization (MR) to investigate the causal association between circulating fatty acids (FAs) and the incidence of 10 human cancer types.
methodsSingle nucleotide polymorphisms (SNPs) significantly associated with circulating FAs were selected from 500,000 UK Biobank blood samples and 114,999 plasma samples from a large GWAS. Summary-level data on 174,006 cancer patients were obtained from the FinnGen biobank. The inverse variance weighted method was used for causal estimation, with additional analyses including MR-Egger regression, weighted median, weighted mode, Cochrane Q test, MR-PRESSO global test, and leave-one-out analyses. Multivariable Mendelian randomization (MVMR) was applied to adjust for potential confounders.
resultThis study found a genetically causal effect of polyunsaturated FAs on kidney cancer incidence (OR: 1.528; 95% CI 1.164-2.266; P = 0.001), which remained significant after Bonferroni adjustment. The causal impact of omega-6, omega-3, and linoleic acid on kidney cancer risk was also observed (omega-6: OR = 1.586, P = 0.002; omega-3: OR = 1.311, P = 0.014; linoleic acid: OR = 1.527, P = 0.007). MVMR confirmed the consistent causal relationship (OR = 1.553, P = 0.0047) after adjusting for multiple variables. Results were validated in a larger cohort.
conclusionsHigher circulating polyunsaturated FAs, especially omega-6, were associated with an increased risk of kidney cancer. Suggestive associations were found in small cell lung, rectal, bladder, pancreatic, and esophageal cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.